BlackRock Advisors’s Genomic Health, Inc. GHDX Stock Holding History

BlackRock Advisors’s Portfolio GHDX Stock Details GHDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$11M	Sell	375,587 -5,607	-1%	-$171K	0.01%	831
2016 Q3	$11M	Sell	381,194 -119,362	-24%	-$3.33M	0.01%	820
2016 Q2	$13M	Sell	500,556 -20,411	-4%	-$542K	0.01%	715
2016 Q1	$12.9M	Sell	520,967 -5,446	-1%	-$149K	0.01%	703
2015 Q4	$18.5M	Sell	526,413 -21,801	-4%	-$584K	0.02%	569
2015 Q3	$11.6M	Sell	548,214 -6,457	-1%	-$166K	0.01%	719
2015 Q2	$15.4M	Buy	554,671 +68,638	+14%	+$1.94M	0.02%	620
2015 Q1	$14.8M	Buy	486,033 +6,741	+1%	+$214K	0.02%	661
2014 Q4	$15.3M	Buy	479,292 +253,921	+113%	+$8.26M	0.02%	651
2014 Q3	$6.38M	Sell	225,371 -3,342	-1%	-$93.2K	0.01%	911
2014 Q2	$6.27M	Buy	228,713 +216,065	+1,708%	+$5.75M	0.01%	911
2014 Q1	$333K	Buy	12,648 +1,055	+9%	+$30.3K	﹤0.01%	2346
2013 Q4	$339K	Sell	11,593 -2,293	-17%	-$72.8K	﹤0.01%	2323
2013 Q3	$425K	Buy	13,886 +3,374	+32%	+$113K	﹤0.01%	2044
2013 Q2	$333K	Buy	+10,512	New	+$345K	﹤0.01%	2131

Other funds holding GHDX

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CWAM

Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

BlackRock Advisors's GHDX Position: Q4 2016 in Review

BlackRock Advisors reduced its Genomic Health, Inc. (GHDX) stake by 1.5% in Q4 2016, selling an estimated $171K and leaving 375,587 shares worth $11M. The position accounts for 0.01% of the portfolio, ranked #831.

BlackRock Advisors first reported a position in GHDX in Q2 2013 and has held it in 15 quarters since. The position peaked at $18.5M in Q4 2015. 133 funds tracked by Wall St. Rank hold GHDX as of Q4 2016.

BlackRock Advisors held 375,587 shares of Genomic Health, Inc. worth $11M as of Q4 2016.
BlackRock Advisors sold 5,607 Genomic Health, Inc. shares in Q4 2016, an estimated $171K.
Genomic Health, Inc. made up 0.01% of BlackRock Advisors's portfolio in Q4 2016, its #831 holding.
BlackRock Advisors first reported a position in Genomic Health, Inc. in Q2 2013 and has held it in 15 quarters since.
BlackRock Advisors's Genomic Health, Inc. position peaked at $18.5M in Q4 2015.
133 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.